Calliditas Therapeutics
Calliditas: Study design change - reduced costs and timeline (Redeye)
2019-09-12 07:30
In this research update, we provide you with our view on the updated Nefigard part-B trial.
info@redeye.se (Redeye.se)
Redeye AB - Redeye.se